Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
After finishing at $0.36 in the prior trading day, Aspire Biopharma Holdings Inc (NASDAQ: ASBP) closed at $0.36, up 1.42%. In other words, the price has increased by $1.42 from its previous closing price. On the day, 3.55 million shares were traded. ASBP stock price reached its highest trading level at $0.3725 during the session, while it also had its lowest trading level at $0.3424.
Ratios:
Our goal is to gain a better understanding of ASBP by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.09 and its Current Ratio is at 0.09.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASBP now has a Market Capitalization of 18042310 and an Enterprise Value of 26309500.
Stock Price History:
The Beta on a monthly basis for ASBP is 0.58, which has changed by -0.96826506 over the last 52 weeks, in comparison to a change of 0.16845357 over the same period for the S&P500. Over the past 52 weeks, ASBP has reached a high of $15.80, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is -15.04%, while the 200-Day Moving Average is calculated to be -86.77%.
Shares Statistics:
The stock has traded on average 22.68M shares per day over the past 3-months and 79922050 shares per day over the last 10 days, according to various share statistics. A total of 49.53M shares are outstanding, with a floating share count of 39.39M. Insiders hold about 20.46% of the company’s shares, while institutions hold 4.13% stake in the company. Shares short for ASBP as of 1757894400 were 2259589 with a Short Ratio of 0.10, compared to 1755216000 on 1287535. Therefore, it implies a Short% of Shares Outstanding of 2259589 and a Short% of Float of 8.63.
